{"symbol":"BSX","fiscalQuarter":"Q4-2020","reportDate":"2021-02-03","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2020","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 2.21%","keyNumbers":[{"metric":"EPS","actual":"$0.23","expected":"N/A","surprise":"-26.05%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges but expressed confidence in long-term growth.","They noted improvements in certain product lines despite the current environment."],"summary":"Overall, management acknowledged the difficulties faced during the quarter but maintained a positive outlook for future growth. They emphasized their commitment to innovation and market expansion."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a significant miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, increasing by 2.21%, likely due to management's optimistic tone about long-term growth and product improvements. Investors may be encouraged by the company's focus on innovation despite current challenges.","metaDescription":"Boston Scientific (BSX) Q4 2020 earnings: EPS missed expectations. Stock up 2.21%. Full breakdown."}}